US Dollar vs Yen

登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。

登録

ホーム
投資
株式
アメリカ
NASDAQ
Tonix Pharmaceuticals Holding Corporation (TNXP)
Tonix Pharmaceuticals Holding Corporation (TNXP) ニュース

TNXP

Tonix Pharmaceuticals (TNXP)

Tonix Pharmaceuticals Holding Corporation

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:TNXP

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/12/23	22 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TNXP	Tonix Pharmaceuticals Holding Corporation
2024/12/23	22 : 00	GlobeNewswire Inc.	Tonix Pharmaceuticals Announces PDUFA Goal Date of August 15, 2025, for FDA Decision on U.S. Marketing Approval for TNX-102 SL for Fibromyalgia	NASDAQ:TNXP	Tonix Pharmaceuticals Holding Corporation
2024/12/21	06 : 17	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TNXP	Tonix Pharmaceuticals Holding Corporation
2024/12/21	06 : 16	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:TNXP	Tonix Pharmaceuticals Holding Corporation
2024/12/17	23 : 25	AllPennyStocks.com	This Micro Cap Is Getting Bid Up Prior To Opening Bell	NASDAQ:TNXP	Tonix Pharmaceuticals Holding Corporation
2024/12/17	22 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TNXP	Tonix Pharmaceuticals Holding Corporation
2024/12/17	22 : 00	GlobeNewswire Inc.	Tonix Pharmaceuticals Announces FDA Acceptance of the New Drug Application (NDA) for TNX-102 SL for Fibromyalgia	NASDAQ:TNXP	Tonix Pharmaceuticals Holding Corporation
2024/12/07	06 : 13	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:TNXP	Tonix Pharmaceuticals Holding Corporation
2024/12/03	21 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TNXP	Tonix Pharmaceuticals Holding Corporation
2024/12/03	21 : 00	GlobeNewswire Inc.	Tonix Pharmaceuticals Announces Expansion of Leadership Team with Two Strategic Hires	NASDAQ:TNXP	Tonix Pharmaceuticals Holding Corporation
2024/11/26	21 : 00	GlobeNewswire Inc.	Tonix Pharmaceuticals to Participate in the NobleCon20 Investor Conference	NASDAQ:TNXP	Tonix Pharmaceuticals Holding Corporation
2024/11/19	06 : 05	GlobeNewswire Inc.	Tonix Pharmaceuticals to Present at the Winter 2024 Investor Summit Virtual	NASDAQ:TNXP	Tonix Pharmaceuticals Holding Corporation
2024/11/18	21 : 00	GlobeNewswire Inc.	Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia at the American College of Rheumatology (ACR) Convergence 2024 Annual Meeting	NASDAQ:TNXP	Tonix Pharmaceuticals Holding Corporation
2024/11/15	06 : 42	Edgar (US Regulatory)	Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]	NASDAQ:TNXP	Tonix Pharmaceuticals Holding Corporation
2024/11/15	06 : 40	Edgar (US Regulatory)	Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]	NASDAQ:TNXP	Tonix Pharmaceuticals Holding Corporation
2024/11/14	06 : 05	GlobeNewswire Inc.	Tonix Pharmaceuticals Announces Poster Presentation at the American College of Rheumatology (ACR) Convergence 2024 Annual Meeting	NASDAQ:TNXP	Tonix Pharmaceuticals Holding Corporation
2024/11/13	23 : 10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TNXP	Tonix Pharmaceuticals Holding Corporation
2024/11/13	23 : 05	GlobeNewswire Inc.	Tonix Pharmaceuticals Announces Peer-Reviewed Publication in mSphere Journal Highlighting the Tolerability of Company’s Single-Dose Mpox and Smallpox Vaccine Candidate TNX-801, in Immune-Compromised Animals	NASDAQ:TNXP	Tonix Pharmaceuticals Holding Corporation
2024/11/13	07 : 10	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:TNXP	Tonix Pharmaceuticals Holding Corporation
2024/11/12	22 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TNXP	Tonix Pharmaceuticals Holding Corporation
2024/11/12	22 : 00	GlobeNewswire Inc.	Tonix Pharmaceuticals Reports Third Quarter 2024 Financial Results and Operational Highlights	NASDAQ:TNXP	Tonix Pharmaceuticals Holding Corporation
2024/11/09	07 : 15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TNXP	Tonix Pharmaceuticals Holding Corporation
2024/11/04	21 : 30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TNXP	Tonix Pharmaceuticals Holding Corporation
2024/11/04	21 : 00	GlobeNewswire Inc.	Tonix Pharmaceuticals Announces Research Agreement with Kenya Medical Research Institute (KEMRI) to Design, Plan and Seek Regulatory Approval for a Phase I Clinical Study of TNX-801 for Mpox in Kenya	NASDAQ:TNXP	Tonix Pharmaceuticals Holding Corporation
2024/11/01	20 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TNXP	Tonix Pharmaceuticals Holding Corporation
2024/11/01	20 : 00	GlobeNewswire Inc.	Tonix Pharmaceuticals Presented Data on Potential Mpox Vaccine TNX-801 at World Vaccine Congress-Europe 2024	NASDAQ:TNXP	Tonix Pharmaceuticals Holding Corporation
2024/10/31	05 : 30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TNXP	Tonix Pharmaceuticals Holding Corporation
2024/10/29	21 : 00	GlobeNewswire Inc.	Tonix Pharmaceuticals to Present at BIO-Europe® 2024	NASDAQ:TNXP	Tonix Pharmaceuticals Holding Corporation
2024/10/29	06 : 16	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TNXP	Tonix Pharmaceuticals Holding Corporation
2024/10/25	21 : 00	GlobeNewswire Inc.	Tonix Pharmaceuticals to Present at the 2024 ThinkEquity Conference	NASDAQ:TNXP	Tonix Pharmaceuticals Holding Corporation

Showing the most relevant articles for your search:NASDAQ:TNXP

1 2 3 4 5 6 7 8 9 10 次へ >>

Financial Select Sector

Gold vs US Dollar

US Dollar vs Euro

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約